Skip to main content
Terug
Watch Compare

Fuse Medical, Inc.

Datakwaliteit: 100%
FZMD
OTC Wholesale Trade Durable Goods Wholesale
€ 0,02
€ 0,00 (0,00%)
Marktkapitalisatie: 1,48 M
Prijs
€ 0,02
Marktkapitalisatie
1,48 M
Dagbereik
€ 0,02 — € 0,02
52-Weeksbereik
€ 0,02 — € 0,10
Volume
142.040
Openen € 0,02
50D / 200D Gem.
€ 0,04
46,81% below
50D / 200D Gem.
€ 0,06
67,53% below

Quick Summary

Belangrijkste Punten

Revenue declined -8,28% annually over 5 years
Net margin of 19,72% shows strong profitability
Generating 18.641,0 in free cash flow
P/E of 0,41 — trading at a low valuation

Groei

Revenue Growth (5Y)
-8,28%
Onder sectorgemiddelde (257,90%)
Revenue (1Y)-8,67%
Earnings (1Y)N/A
FCF Growth (3Y)-59,85%

Kwaliteit

Return on Equity
N/A
ROIC-3,30%
Net Margin19,72%
Op. Margin-1,30%

Veiligheid

Debt / Equity
N/A
Current Ratio1,06
Interest Coverage-1,13

Waardering

PE (TTM)
0,41
Boven sectorgemiddelde (-27,54)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Wholesale Trade sector mediaan (3 peers)
Metriek Aandeel Sector Mediaan
P/E 0,4 -27,5
P/B 1,6
ROE % -2,8
Net Margin % 19,7 -199494,9
Rev Growth 5Y % -8,3 257,9
D/E 0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y) -8,67% Revenue Growth (3Y) -6,66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8,28% Earnings Growth (5Y) -5,94%
Profitability
Revenue (TTM) 18,40 M Net Income (TTM) 3,63 M
ROE N/A ROA 19,23%
Gross Margin 64,95% Operating Margin -1,30%
Net Margin 19,72% Free Cash Flow (TTM) 18.641,0
ROIC -3,30% FCF Growth (3Y) -59,85%
Safety
Debt / Equity N/A Current Ratio 1,06
Interest Coverage -1,13 Asset Turnover 0,98
Working Capital 754.339 Tangible Book Value -3,33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0,41 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,26%
Market Cap 1,48 M Enterprise Value 1,22 M
Per Share
EPS (Diluted TTM) 0,04 Revenue / Share 0,25
FCF / Share 0,00 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) -9,64%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 0,51%
SBC-Adj. FCF 1.649 Growth Momentum -0,39

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue 18,64 M 20,41 M 21,40 M 22,90 M 26,34 M
Net Income 3,10 M -1,59 M -1,43 M -3,32 M 3,96 M
EPS (Diluted) 0,04 -0,02 -0,02 -0,05 0,06
Gross Profit 11,54 M 11,94 M 12,70 M 11,14 M 12,99 M
Operating Income -815.072,0 -2,20 M -1,03 M -4,35 M -1,96 M
EBITDA
R&D Expenses
SG&A Expenses 6,54 M 7,01 M 6,54 M 8,47 M 8,47 M
D&A 137.403,0 67.638,0 104.143,0 107.073,0 49.685,0
Interest Expense 171.294,0 78.230,0 94.953,0 121.633,0 133.944,0
Income Tax 23.655,0 17.723,0 18.993,0 781.085,0 -386.784,0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 19,76 M 18,30 M 17,42 M 18,38 M 22,17 M
Total Liabilities 20,07 M 21,74 M 19,53 M 19,60 M 20,71 M
Shareholders' Equity -310.854,0 -3,43 M -2,11 M -1,22 M 1,47 M
Total Debt
Cash & Equivalents 147.854,0 553.190,0 1,19 M 1,10 M 844.314,0
Current Assets 13,77 M 12,82 M 12,62 M 15,17 M 17,18 M
Current Liabilities 12,39 M 9,94 M 7,25 M 7,96 M 7,12 M